by mediaid pharmacy | Dec 26, 2025 | Blogs
Olaparib 150 mg is an innovative cancer treatment that provides hope to patients diagnosed with ovarian, breast, and pancreatic cancers, particularly those with BRCA1 or BRCA2 gene mutations. As part of the class of drugs known as PARP inhibitors, Olaparib works by...
by mediaid pharmacy | Nov 10, 2023 | Lung Cancer Treatment
Lung cancer is a challenging disease, affecting millions of people worldwide. Thankfully, medical science has made significant progress in finding treatments that offer hope and relief. One such advancement is the use of a medication called Osicent Osimertinib 80 mg....
